{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:00:22Z","timestamp":1784602822669,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:00:00Z","timestamp":1647043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:00:00Z","timestamp":1647043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We aimed to develop and validate a nomogram model, which could predict metachronous liver metastasis in colorectal cancer within two years after diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was performed on colorectal cancer patients who were admitted to Beijing Shijitan Hospital from January 1, 2016 to June 30, 2019. The least absolute shrinkage and selection operator (LASSO) regression model was used to optimize feature selection for susceptibility to metachronous liver metastasis in colorectal cancer. Multivariable logistic regression analysis was applied to establish a predictive model through incorporating features selected in the LASSO regression model. C-index, receiver operating characteristic (ROC) curve, calibration plot, and decision curve analysis (DCA) were employed to assess discrimination, distinctiveness, consistency with actual occurrence risk, and clinical utility of candidate predictive model. Internal validation was assessed with bootstrapping method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Predictors contained in candidate prediction nomogram included age, CEA, vascular invasion, T stage, N stage, family history of cancer, and KRAS mutation. This model displayed good discrimination with a C-index of 0.787 (95% confidence interval: 0.728\u20130.846) and good calibration, whereas area under the ROC curve (AUC) of 0.786. Internal validation obtained C-index of 0.786, and AUC of validation cohort is 0.784. Based on DCA, with threshold probability range from 1 to 60%; this predictive model might identify colorectal cancer metachronous liver metastasis to achieve a net clinical benefit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We have developed and validated a prognostic nomogram with good discriminative and high accuracy to predict metachronous liver metastasis in CRC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02558-6","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T13:02:59Z","timestamp":1647090179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Predicting metachronous liver metastasis in patients with colorectal cancer: development and assessment of a new nomogram"],"prefix":"10.1186","volume":"20","author":[{"given":"Mengdi","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,12]]},"reference":[{"key":"2558_CR1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.","DOI":"10.3322\/caac.21660"},{"key":"2558_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","volume":"55","author":"CL Stewart","year":"2018","unstructured":"Stewart CL, Warner S, Ito K, Raoof M, Wu GX, Kessler J, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55:330\u201379.","journal-title":"Curr Probl Surg"},{"key":"2558_CR3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3389\/fonc.2020.00716","volume":"10","author":"L Wu","year":"2020","unstructured":"Wu L, Fu J, Chen Y, Wang L, Zheng S. Early T stage is associated with poor prognosis in patients with metastatic liver colorectal cancer. Front Oncol. 2020;10:716.","journal-title":"Front Oncol"},{"key":"2558_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145\u201364.","journal-title":"CA Cancer J Clin"},{"key":"2558_CR5","doi-asserted-by":"publisher","first-page":"100570","DOI":"10.1016\/j.trre.2020.100570","volume":"34","author":"D Giannis","year":"2020","unstructured":"Giannis D, Sideris G, Kakos CD, Katsaros I, Ziogas IA. The role of liver transplantation for colorectal liver metastases: a systematic review and pooled analysis. Transplant Rev (Orlando). 2020;34:100570.","journal-title":"Transplant Rev (Orlando)"},{"key":"2558_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ejso.2010.03.009","volume":"36","author":"E Gregoire","year":"2010","unstructured":"Gregoire E, Hoti E, Gorden DL, de la Serna S, Pascal G, Azoulay D. Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. Eur J Surg Oncol. 2010;36:568\u201374.","journal-title":"Eur J Surg Oncol"},{"key":"2558_CR7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s12094-019-02277-7","volume":"22","author":"GA Colloca","year":"2020","unstructured":"Colloca GA, Venturino A, Guarneri D. Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer. Clin Transl Oncol. 2020;22:1399\u2013406.","journal-title":"Clin Transl Oncol"},{"key":"2558_CR8","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1245\/s10434-020-08622-3","volume":"27","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Xiang JX, Zhang XF, Pawlik TM. ASO author reflections: a nomogram to predict recurrence after curative-intent resection for neuroendocrine liver metastasis. Ann Surg Oncol. 2020;27:3727\u20138.","journal-title":"Ann Surg Oncol"},{"key":"2558_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.eururo.2015.01.032","volume":"68","author":"LA Kluth","year":"2015","unstructured":"Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A, et al. Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature. Eur Urol. 2015;68:238\u201353.","journal-title":"Eur Urol"},{"key":"2558_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jcmg.2017.03.018","volume":"11","author":"B \u00d3 Hartaigh","year":"2018","unstructured":"\u00d3 Hartaigh B, Gransar H, Callister T, Shaw LJ, Schulman-Marcus J, Stuijfzand WJ, et al. Development and validation of a simple-to-use nomogram for predicting 5-, 10-, and 15-year survival in asymptomatic adults undergoing coronary artery calcium scoring. JACC Cardiovasc Imaging. 2018;11:450\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2558_CR11","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1200\/JCO.19.02362","volume":"38","author":"SN Lo","year":"2020","unstructured":"Lo SN, Ma J, Scolyer RA, Haydu LE, Stretch JR, Saw RPM, et al. Improved risk prediction calculator for sentinel node positivity in patients with melanoma: the melanoma institute australia nomogram. J Clin Oncol. 2020;38:2719\u201327.","journal-title":"J Clin Oncol"},{"key":"2558_CR12","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","volume":"26","author":"W Sauerbrei","year":"2007","unstructured":"Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512\u201328.","journal-title":"Stat Med"},{"key":"2558_CR13","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34:2157\u201364.","journal-title":"J Clin Oncol"},{"key":"2558_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"2558_CR15","doi-asserted-by":"crossref","unstructured":"Liu W, Zhang W, Xu Y, Li YH, Xing BC. A prognostic scoring system to predict survival outcome of resectable colorectal liver metastases in this modern era. Ann Surg Oncol. 2021;28(12):7709-7718.","DOI":"10.1245\/s10434-021-10143-6"},{"key":"2558_CR16","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","volume":"23","author":"MJ Pencina","year":"2004","unstructured":"Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109\u201323.","journal-title":"Stat Med"},{"key":"2558_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26:565\u201374.","journal-title":"Med Decis Mak"},{"key":"2558_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1477-7819-12-391","volume":"12","author":"LC Bredt","year":"2014","unstructured":"Bredt LC, Rachid AF. Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis. World J Surg Oncol. 2014;12:391.","journal-title":"World J Surg Oncol"},{"key":"2558_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/1471-2407-14-810","volume":"14","author":"C Hackl","year":"2014","unstructured":"Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt HJ. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14:810.","journal-title":"BMC Cancer"},{"key":"2558_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/bjs.10457","volume":"104","author":"JH Angelsen","year":"2017","unstructured":"Angelsen JH, Horn A, Sorbye H, Eide GE, Loes IM, Viste A. Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway. Br J Surg. 2017;104:580\u20139.","journal-title":"Br J Surg"},{"key":"2558_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000354310","volume":"30","author":"SK John","year":"2013","unstructured":"John SK, Robinson SM, Rehman S, Harrison B, Vallance A, French JJ, et al. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. Dig Surg. 2013;30:293\u2013301.","journal-title":"Dig Surg"},{"key":"2558_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00280-015-2780-1","volume":"76","author":"I Nakayama","year":"2015","unstructured":"Nakayama I, Suenaga M, Wakatsuki T, Ichimura T, Ozaka M, Takahari D, et al. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer. Cancer Chemother Pharmacol. 2015;76:133\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"2558_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1015-9584(09)60394-8","volume":"32","author":"WW Ng","year":"2009","unstructured":"Ng WW, Cheung YS, Wong J, Lee KF, Lai PB. A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis. Asian J Surg. 2009;32(4):189\u201397.","journal-title":"Asian J Surg"},{"key":"2558_CR24","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1245\/s10434-012-2356-9","volume":"19","author":"Z Dexiang","year":"2012","unstructured":"Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, et al. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Ann Surg Oncol. 2012;19:2860\u20138.","journal-title":"Ann Surg Oncol"},{"key":"2558_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12957-019-1771-9","volume":"17","author":"J Engstrand","year":"2019","unstructured":"Engstrand J, Stromberg C, Nilsson H, Freedman J, Jonas E. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition. World J Surg Oncol. 2019;17:228.","journal-title":"World J Surg Oncol"},{"key":"2558_CR26","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.2147\/CMAR.S313113","volume":"13","author":"T Jiang","year":"2021","unstructured":"Jiang T, Liu S, Wu X, Liu X, Li W, Yang S, et al. Nomogram to predict distant metastasis probability for pathological complete response rectal cancer patients after neoadjuvant chemoradiotherapy. Cancer Manag Res. 2021;13:4751\u201361.","journal-title":"Cancer Manag Res"},{"key":"2558_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.21037\/atm.2019.09.127","volume":"7","author":"C Zhou","year":"2019","unstructured":"Zhou C, Liu HS, Liu XH, Zheng XB, Hu T, Liang ZX, et al. Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors. Ann Transl Med. 2019;7:543.","journal-title":"Ann Transl Med"},{"key":"2558_CR28","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1002\/cam4.2896","volume":"9","author":"J Liu","year":"2020","unstructured":"Liu J, Huang X, Yang W, Li C, Li Z, Zhang C, et al. Nomogram for predicting overall survival in stage II-III colorectal cancer. Cancer Med. 2020;9:2363\u201371.","journal-title":"Cancer Med"},{"key":"2558_CR29","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/j.clcc.2018.03.011","volume":"17","author":"C Kim","year":"2018","unstructured":"Kim C, Kim WR, Kim KY, Chon HJ, Beom SH, Kim H, et al. Predictive nomogram for recurrence of stage I colorectal cancer after curative resection. Clin Colorectal Cancer. 2018;17:e513\u20138.","journal-title":"Clin Colorectal Cancer"},{"key":"2558_CR30","doi-asserted-by":"crossref","unstructured":"Borumandnia N, Doosti H, Jalali A, Khodakarim S, Charati JY, Pourhoseingholi MA, Talebi A, Agah S. Nomogram to predict the overall survival of colorectal cancer patients: a multicenter national study. Int J Environ Res Public Health. 2021;18(15):7734.","DOI":"10.3390\/ijerph18157734"},{"key":"2558_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.21037\/jgo-20-329","volume":"12","author":"Q Meng","year":"2021","unstructured":"Meng Q, Zheng N, Wen R, Sui J, Zhang W. Preoperative nomogram to predict survival following colorectal cancer liver metastasis simultaneous resection. J Gastrointest Oncol. 2021;12:556\u201367.","journal-title":"J Gastrointest Oncol"},{"key":"2558_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12876-021-01692-x","volume":"21","author":"Z Liu","year":"2021","unstructured":"Liu Z, Xu Y, Xu G, Baklaushev VP, Chekhonin VP, Peltzer K, et al. Nomogram for predicting overall survival in colorectal cancer with distant metastasis. BMC Gastroenterol. 2021;21:103.","journal-title":"BMC Gastroenterol"},{"key":"2558_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/gastro\/goaa092","volume":"9","author":"S Dai","year":"2021","unstructured":"Dai S, Ye Y, Kong X, Li J, Ding K. A predictive model for early recurrence of colorectal-cancer liver metastases based on clinical parameters. Gastroenterol Rep (Oxf). 2021;9:241\u201351.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"2558_CR34","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00384-021-03920-y","volume":"36","author":"X Ding","year":"2021","unstructured":"Ding X, Tian S, Hu J, Wang G, Yu X, Fu D, et al. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study. Int J Color Dis. 2021;36:1915\u201327.","journal-title":"Int J Color Dis"},{"key":"2558_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ctm2.20","volume":"10","author":"S Mo","year":"2020","unstructured":"Mo S, Cai X, Zhou Z, Li Y, Hu X, Ma X, et al. Nomograms for predicting specific distant metastatic sites and overall survival of colorectal cancer patients: A large population-based real-world study. Clin Transl Med. 2020;10:169\u201381.","journal-title":"Clin Transl Med"},{"key":"2558_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00384-020-03722-8","volume":"36","author":"M Tang","year":"2021","unstructured":"Tang M, Wang H, Cao Y, Zeng Z, Shan X, Wang L. Nomogram for predicting occurrence and prognosis of liver metastasis in colorectal cancer: a population-based study. Int J Color Dis. 2021;36:271\u201382.","journal-title":"Int J Color Dis"},{"key":"2558_CR37","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","volume":"373","author":"JA Sparano","year":"2015","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med. 2015;373:2005\u201314.","journal-title":"N Engl J Med"},{"key":"2558_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/1055-9965.EPI-04-0404","volume":"14","author":"E Gorelik","year":"2005","unstructured":"Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, et al. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomark Prev. 2005;14:981\u20137.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2558_CR39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1245\/s10434-006-9215-5","volume":"14","author":"MS Tsai","year":"2007","unstructured":"Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14:786\u201394.","journal-title":"Ann Surg Oncol"},{"key":"2558_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jjco\/hyd003","volume":"30","author":"WS Wang","year":"2000","unstructured":"Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, et al. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol. 2000;30:12\u20136.","journal-title":"Jpn J Clin Oncol"},{"key":"2558_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1081\/CNV-58878","volume":"23","author":"M Goldstein","year":"2005","unstructured":"Goldstein M, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Investig. 2005;23:338\u201351.","journal-title":"Cancer Investig"},{"issue":"10","key":"2558_CR42","first-page":"1431","volume":"69","author":"MS Khan","year":"2019","unstructured":"Khan MS, Khan MA, Akbar SA, Bakar MA, Khattak S, Syed AA. Prognostic significance of pre- and post-operative serum carcinoembryonic antigen levels in patients presented with rectal carcinoma; an experience from Shaukat Khanum Memorial Cancer Hospital and Research Center Lahore. J Pak Med Assoc. 2019;69(10):1431\u20136.","journal-title":"J Pak Med Assoc"},{"key":"2558_CR43","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s10350-008-9406-1","volume":"51","author":"M Hara","year":"2008","unstructured":"Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Dis Colon Rectum. 2008;51:1675\u201380.","journal-title":"Dis Colon Rectum"},{"key":"2558_CR44","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s11605-008-0508-9","volume":"12","author":"M Bockhorn","year":"2008","unstructured":"Bockhorn M, Frilling A, Fruhauf NR, Neuhaus J, Molmenti E, Trarbach T, et al. Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference? J Gastrointest Surg. 2008;12:1399\u2013405.","journal-title":"J Gastrointest Surg"},{"key":"2558_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4251\/wjgo.v8.i1.128","volume":"8","author":"M Cho","year":"2016","unstructured":"Cho M, Akiba C, Lau C, Smith D, Telatar M, Afkhami M, et al. Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases. World J Gastrointest Oncol. 2016;8:128\u201335.","journal-title":"World J Gastrointest Oncol"},{"key":"2558_CR46","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00268-010-0881-x","volume":"35","author":"SC Chuang","year":"2011","unstructured":"Chuang SC, Su YC, Lu CY, Hsu HT, Sun LC, Shih YL, et al. Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. World J Surg. 2011;35:424\u20139.","journal-title":"World J Surg"},{"key":"2558_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10585-017-9838-x","volume":"34","author":"AM Mohr","year":"2017","unstructured":"Mohr AM, Gould JJ, Kubik JL, Talmon GA, Casey CA, Thomas P, et al. Enhanced colorectal cancer metastases in the alcohol-injured liver. Clin Exp Metastasis. 2017;34:171\u201384.","journal-title":"Clin Exp Metastasis"},{"key":"2558_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.25301\/JPDA.284.201","volume":"69","author":"MS Khan","year":"2019","unstructured":"Khan MS, Bakar MA, Saba A, Khan MA, Akbar SA, Islam Nasir IU. Risk factors effecting development of metachronous liver metastasis in rectal cancer patients after curative surgical resection. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore experience. J Pak Med Assoc. 2019;69:201\u20134.","journal-title":"J Pak Med Assoc"},{"key":"2558_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jmoldx.2011.03.002","volume":"13","author":"K Balschun","year":"2011","unstructured":"Balschun K, Haag J, Wenke AK, von Schonfels W, Schwarz NT, Rocken C. KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications. J Mol Diagn. 2011;13:436\u201345.","journal-title":"J Mol Diagn"},{"key":"2558_CR50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.suronc.2018.05.012","volume":"27","author":"DI Tsilimigras","year":"2018","unstructured":"Tsilimigras DI, Ntanasis-Stathopoulos I, Bagante F, Moris D, Cloyd J, Spartalis E, et al. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. Surg Oncol. 2018;27:280\u20138.","journal-title":"Surg Oncol"},{"key":"2558_CR51","doi-asserted-by":"crossref","unstructured":"Nakayama I, Hirota T, Shinozaki E. BRAF mutation in colorectal cancers: from prognostic marker to targetable mutation. Cancers (Basel). 2020;12(11):3236.","DOI":"10.3390\/cancers12113236"},{"key":"2558_CR52","doi-asserted-by":"publisher","first-page":"e180996","DOI":"10.1001\/jamasurg.2018.0996","volume":"153","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Buettner S, Andreatos N, Kim Y, Wagner D, Sasaki K, et al. Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer. JAMA Surg. 2018;153:e180996.","journal-title":"JAMA Surg"},{"key":"2558_CR53","first-page":"674","volume":"5","author":"Q Feng","year":"2015","unstructured":"Feng Q, Liang L, Ren L, Chen J, Wei Y, Chang W, et al. A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases. Am J Cancer Res. 2015;5:674\u201388.","journal-title":"Am J Cancer Res"},{"key":"2558_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bjc.6605737","volume":"103","author":"LJ Mekenkamp","year":"2010","unstructured":"Mekenkamp LJ, Koopman M, Teerenstra S, van Krieken JH, Mol L, Nagtegaal ID, et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer. 2010;103:159\u201364.","journal-title":"Br J Cancer"},{"key":"2558_CR55","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1245\/s10434-017-5818-2","volume":"24","author":"LT Seeberg","year":"2017","unstructured":"Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, et al. Survival impact of primary tumor lymph node status and circulating tumor cells in patients with colorectal liver metastases. Ann Surg Oncol. 2017;24:2113\u201321.","journal-title":"Ann Surg Oncol"},{"key":"2558_CR56","doi-asserted-by":"crossref","unstructured":"Filip S, Vymetalkova V, Petera J, Vodickova L, Kubecek O, John S, Cecka F, Krupova M, Manethova M, Cervena K, Vodicka P. Distant metastasis in colorectal cancer patients-do we have new predicting clinicopathological and molecular biomarkers? A comprehensive review. Int J Mol Sci. 2020;21(15):5255.","DOI":"10.3390\/ijms21155255"},{"key":"2558_CR57","first-page":"275","volume":"90","author":"G Li Destri","year":"2019","unstructured":"Li Destri G, La Greca G, Pesce A, Conti E, Puleo S, Portale TR, et al. Lymph node ratio and liver metachronous metastases in colorectal cancer. Ann Ital Chir. 2019;90:275\u201380.","journal-title":"Ann Ital Chir"},{"issue":"Suppl 3","key":"2558_CR58","doi-asserted-by":"publisher","first-page":"S638","DOI":"10.1245\/s10434-015-4562-8","volume":"22","author":"JA de Ridder","year":"2015","unstructured":"de Ridder JA, Knijn N, Wiering B, de Wilt JH, Nagtegaal ID. Lymphatic invasion is an independent adverse prognostic factor in patients with colorectal liver metastasis. Ann Surg Oncol. 2015;22(Suppl 3):S638\u201345.","journal-title":"Ann Surg Oncol"},{"key":"2558_CR59","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380.","journal-title":"Lancet"},{"key":"2558_CR60","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2214\/AJR.15.15785","volume":"207","author":"E Nerad","year":"2016","unstructured":"Nerad E, Lahaye MJ, Maas M, Nelemans P, Bakers FC, Beets GL, et al. Diagnostic accuracy of CT for local staging of colon cancer: a systematic review and meta-analysis. AJR Am J Roentgenol. 2016;207:984\u201395.","journal-title":"AJR Am J Roentgenol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02558-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02558-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T04:10:49Z","timestamp":1666498249000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02558-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2558"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02558-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,12]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients gave written informed consent to participate in the study and to have their medical records released. Our institution's local Ethics Committee approved the study design (#[ sjtky11-1x-2021(106)]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}